Characterisation	O
of	O
methicillin	B:C1265292
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
clinical	O
isolates	O
from	O
animals	O
in	O
New	O
Zealand	I:C0027978
,	O
2012	O
-	O
2013	O
,	O
and	O
subclinical	O
colonisation	O
in	O
dogs	O
and	O
cats	O
in	O
Auckland	O
.	O

Characterisation	O
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
clinical	O
isolates	B:C1764827
from	O
animals	O
in	O
New	O
Zealand	I:C0027978
,	O
2012	O
-	O
2013	O
,	O
and	O
subclinical	O
colonisation	O
in	O
dogs	O
and	O
cats	O
in	O
Auckland	O
.	O

Characterisation	O
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
clinical	O
isolates	O
from	O
animals	B:C0003062
in	O
New	O
Zealand	I:C0027978
,	O
2012	O
-	O
2013	O
,	O
and	O
subclinical	O
colonisation	O
in	O
dogs	O
and	O
cats	O
in	O
Auckland	O
.	O

Characterisation	O
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
clinical	O
isolates	O
from	O
animals	O
in	O
New	B:C0027978
Zealand	I:C0027978
,	O
2012	O
-	O
2013	O
,	O
and	O
subclinical	O
colonisation	O
in	O
dogs	O
and	O
cats	O
in	O
Auckland	O
.	O

Characterisation	O
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
clinical	O
isolates	O
from	O
animals	O
in	O
New	O
Zealand	I:C0027978
,	O
2012	O
-	O
2013	O
,	O
and	O
subclinical	O
colonisation	B:C2242741
in	O
dogs	O
and	O
cats	O
in	O
Auckland	O
.	O

Characterisation	O
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
clinical	O
isolates	O
from	O
animals	O
in	O
New	O
Zealand	I:C0027978
,	O
2012	O
-	O
2013	O
,	O
and	O
subclinical	O
colonisation	O
in	O
dogs	B:C0012984
and	O
cats	O
in	O
Auckland	O
.	O

Characterisation	O
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
clinical	O
isolates	O
from	O
animals	O
in	O
New	O
Zealand	I:C0027978
,	O
2012	O
-	O
2013	O
,	O
and	O
subclinical	O
colonisation	O
in	O
dogs	O
and	O
cats	B:C0007450
in	O
Auckland	O
.	O

To	O
characterise	O
methicillin	B:C1265292
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
(	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
)	O
isolates	O
from	O
infection	O
sites	I:C0578491
in	O
animals	O
in	O
New	O
Zealand	I:C0027978
and	O
assess	O
the	O
prevalence	O
of	O
subclinical	O
MRSA	O
colonisation	I:C2242741
in	O
dogs	O
and	O
cats	O
attending	O
veterinary	O
clinics	I:C2936717
in	O
Auckland	O
.	O

To	O
characterise	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
(	O
methicillin	B:C1265292
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
)	O
isolates	O
from	O
infection	O
sites	I:C0578491
in	O
animals	O
in	O
New	O
Zealand	I:C0027978
and	O
assess	O
the	O
prevalence	O
of	O
subclinical	O
MRSA	O
colonisation	I:C2242741
in	O
dogs	O
and	O
cats	O
attending	O
veterinary	O
clinics	I:C2936717
in	O
Auckland	O
.	O

To	O
characterise	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
(	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
)	O
isolates	B:C1764827
from	O
infection	O
sites	I:C0578491
in	O
animals	O
in	O
New	O
Zealand	I:C0027978
and	O
assess	O
the	O
prevalence	O
of	O
subclinical	O
MRSA	O
colonisation	I:C2242741
in	O
dogs	O
and	O
cats	O
attending	O
veterinary	O
clinics	I:C2936717
in	O
Auckland	O
.	O

To	O
characterise	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
(	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
)	O
isolates	O
from	O
infection	B:C0578491
sites	I:C0578491
in	O
animals	O
in	O
New	O
Zealand	I:C0027978
and	O
assess	O
the	O
prevalence	O
of	O
subclinical	O
MRSA	O
colonisation	I:C2242741
in	O
dogs	O
and	O
cats	O
attending	O
veterinary	O
clinics	I:C2936717
in	O
Auckland	O
.	O

To	O
characterise	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
(	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
)	O
isolates	O
from	O
infection	O
sites	I:C0578491
in	O
animals	B:C0003062
in	O
New	O
Zealand	I:C0027978
and	O
assess	O
the	O
prevalence	O
of	O
subclinical	O
MRSA	O
colonisation	I:C2242741
in	O
dogs	O
and	O
cats	O
attending	O
veterinary	O
clinics	I:C2936717
in	O
Auckland	O
.	O

To	O
characterise	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
(	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
)	O
isolates	O
from	O
infection	O
sites	I:C0578491
in	O
animals	O
in	O
New	B:C0027978
Zealand	I:C0027978
and	O
assess	O
the	O
prevalence	O
of	O
subclinical	O
MRSA	O
colonisation	I:C2242741
in	O
dogs	O
and	O
cats	O
attending	O
veterinary	O
clinics	I:C2936717
in	O
Auckland	O
.	O

To	O
characterise	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
(	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
)	O
isolates	O
from	O
infection	O
sites	I:C0578491
in	O
animals	O
in	O
New	O
Zealand	I:C0027978
and	O
assess	O
the	O
prevalence	O
of	O
subclinical	O
MRSA	B:C2242741
colonisation	I:C2242741
in	O
dogs	O
and	O
cats	O
attending	O
veterinary	O
clinics	I:C2936717
in	O
Auckland	O
.	O

To	O
characterise	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
(	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
)	O
isolates	O
from	O
infection	O
sites	I:C0578491
in	O
animals	O
in	O
New	O
Zealand	I:C0027978
and	O
assess	O
the	O
prevalence	O
of	O
subclinical	O
MRSA	O
colonisation	I:C2242741
in	O
dogs	B:C0012984
and	O
cats	O
attending	O
veterinary	O
clinics	I:C2936717
in	O
Auckland	O
.	O

To	O
characterise	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
(	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
)	O
isolates	O
from	O
infection	O
sites	I:C0578491
in	O
animals	O
in	O
New	O
Zealand	I:C0027978
and	O
assess	O
the	O
prevalence	O
of	O
subclinical	O
MRSA	O
colonisation	I:C2242741
in	O
dogs	O
and	O
cats	B:C0007450
attending	O
veterinary	O
clinics	I:C2936717
in	O
Auckland	O
.	O

To	O
characterise	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
(	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
)	O
isolates	O
from	O
infection	O
sites	I:C0578491
in	O
animals	O
in	O
New	O
Zealand	I:C0027978
and	O
assess	O
the	O
prevalence	O
of	O
subclinical	O
MRSA	O
colonisation	I:C2242741
in	O
dogs	O
and	O
cats	O
attending	O
veterinary	B:C2936717
clinics	I:C2936717
in	O
Auckland	O
.	O

methicillin	B:C1265292
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
isolates	O
from	O
clinical	O
specimens	O
obtained	O
by	O
the	O
main	O
New	O
Zealand	I:C0027978
veterinary	O
diagnostic	I:C0022877
laboratories	I:C0022877
between	O
June	O
2012	O
and	O
June	O
2013	O
,	O
were	O
genotypically	O
characterised	O
by	O
DNA	O
microarray	I:C1522053
hybridisation	I:C1522053
analysis	I:C1522053
and	O
spa	O
typing	O
.	O

methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
isolates	B:C1764827
from	O
clinical	O
specimens	O
obtained	O
by	O
the	O
main	O
New	O
Zealand	I:C0027978
veterinary	O
diagnostic	I:C0022877
laboratories	I:C0022877
between	O
June	O
2012	O
and	O
June	O
2013	O
,	O
were	O
genotypically	O
characterised	O
by	O
DNA	O
microarray	I:C1522053
hybridisation	I:C1522053
analysis	I:C1522053
and	O
spa	O
typing	O
.	O

methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
isolates	O
from	O
clinical	O
specimens	O
obtained	O
by	O
the	O
main	O
New	B:C0027978
Zealand	I:C0027978
veterinary	O
diagnostic	I:C0022877
laboratories	I:C0022877
between	O
June	O
2012	O
and	O
June	O
2013	O
,	O
were	O
genotypically	O
characterised	O
by	O
DNA	O
microarray	I:C1522053
hybridisation	I:C1522053
analysis	I:C1522053
and	O
spa	O
typing	O
.	O

methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
isolates	O
from	O
clinical	O
specimens	O
obtained	O
by	O
the	O
main	O
New	O
Zealand	I:C0027978
veterinary	B:C0022877
diagnostic	I:C0022877
laboratories	I:C0022877
between	O
June	O
2012	O
and	O
June	O
2013	O
,	O
were	O
genotypically	O
characterised	O
by	O
DNA	O
microarray	I:C1522053
hybridisation	I:C1522053
analysis	I:C1522053
and	O
spa	O
typing	O
.	O

methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
isolates	O
from	O
clinical	O
specimens	O
obtained	O
by	O
the	O
main	O
New	O
Zealand	I:C0027978
veterinary	O
diagnostic	I:C0022877
laboratories	I:C0022877
between	O
June	O
2012	O
and	O
June	O
2013	O
,	O
were	O
genotypically	O
characterised	O
by	O
DNA	B:C1522053
microarray	I:C1522053
hybridisation	I:C1522053
analysis	I:C1522053
and	O
spa	O
typing	O
.	O

methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
isolates	O
from	O
clinical	O
specimens	O
obtained	O
by	O
the	O
main	O
New	O
Zealand	I:C0027978
veterinary	O
diagnostic	I:C0022877
laboratories	I:C0022877
between	O
June	O
2012	O
and	O
June	O
2013	O
,	O
were	O
genotypically	O
characterised	O
by	O
DNA	O
microarray	I:C1522053
hybridisation	I:C1522053
analysis	I:C1522053
and	O
spa	B:C0038164
typing	O
.	O

methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
isolates	O
from	O
clinical	O
specimens	O
obtained	O
by	O
the	O
main	O
New	O
Zealand	I:C0027978
veterinary	O
diagnostic	I:C0022877
laboratories	I:C0022877
between	O
June	O
2012	O
and	O
June	O
2013	O
,	O
were	O
genotypically	O
characterised	O
by	O
DNA	O
microarray	I:C1522053
hybridisation	I:C1522053
analysis	I:C1522053
and	O
spa	O
typing	B:C0087124
.	O

In	O
addition	O
,	O
nasal	B:C0222095
or	O
perineal	O
skin	I:C0222176
swabs	O
collected	O
from	O
a	O
cross-sectional	O
sample	O
of	O
dogs	O
(	O
n=361	O
)	O
and	O
cats	O
(	O
n=225	O
)	O
attending	O
29	O
veterinary	O
clinics	I:C2936717
in	O
Auckland	O
during	O
the	O
same	O
period	O
were	O
analysed	O
for	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
by	O
culture	O
.	O

In	O
addition	O
,	O
nasal	O
or	O
perineal	B:C0222176
skin	I:C0222176
swabs	O
collected	O
from	O
a	O
cross-sectional	O
sample	O
of	O
dogs	O
(	O
n=361	O
)	O
and	O
cats	O
(	O
n=225	O
)	O
attending	O
29	O
veterinary	O
clinics	I:C2936717
in	O
Auckland	O
during	O
the	O
same	O
period	O
were	O
analysed	O
for	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
by	O
culture	O
.	O

In	O
addition	O
,	O
nasal	O
or	O
perineal	O
skin	I:C0222176
swabs	O
collected	O
from	O
a	O
cross-sectional	O
sample	O
of	O
dogs	B:C0012984
(	O
n=361	O
)	O
and	O
cats	O
(	O
n=225	O
)	O
attending	O
29	O
veterinary	O
clinics	I:C2936717
in	O
Auckland	O
during	O
the	O
same	O
period	O
were	O
analysed	O
for	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
by	O
culture	O
.	O

In	O
addition	O
,	O
nasal	O
or	O
perineal	O
skin	I:C0222176
swabs	O
collected	O
from	O
a	O
cross-sectional	O
sample	O
of	O
dogs	O
(	O
n=361	O
)	O
and	O
cats	B:C0007450
(	O
n=225	O
)	O
attending	O
29	O
veterinary	O
clinics	I:C2936717
in	O
Auckland	O
during	O
the	O
same	O
period	O
were	O
analysed	O
for	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
by	O
culture	O
.	O

In	O
addition	O
,	O
nasal	O
or	O
perineal	O
skin	I:C0222176
swabs	O
collected	O
from	O
a	O
cross-sectional	O
sample	O
of	O
dogs	O
(	O
n=361	O
)	O
and	O
cats	O
(	O
n=225	O
)	O
attending	O
29	O
veterinary	B:C2936717
clinics	I:C2936717
in	O
Auckland	O
during	O
the	O
same	O
period	O
were	O
analysed	O
for	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
by	O
culture	O
.	O

In	O
addition	O
,	O
nasal	O
or	O
perineal	O
skin	I:C0222176
swabs	O
collected	O
from	O
a	O
cross-sectional	O
sample	O
of	O
dogs	O
(	O
n=361	O
)	O
and	O
cats	O
(	O
n=225	O
)	O
attending	O
29	O
veterinary	O
clinics	I:C2936717
in	O
Auckland	O
during	O
the	O
same	O
period	O
were	O
analysed	B:C0936012
for	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
by	O
culture	O
.	O

In	O
addition	O
,	O
nasal	O
or	O
perineal	O
skin	I:C0222176
swabs	O
collected	O
from	O
a	O
cross-sectional	O
sample	O
of	O
dogs	O
(	O
n=361	O
)	O
and	O
cats	O
(	O
n=225	O
)	O
attending	O
29	O
veterinary	O
clinics	I:C2936717
in	O
Auckland	O
during	O
the	O
same	O
period	O
were	O
analysed	O
for	O
methicillin	B:C1265292
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
by	O
culture	O
.	O

In	O
addition	O
,	O
nasal	O
or	O
perineal	O
skin	I:C0222176
swabs	O
collected	O
from	O
a	O
cross-sectional	O
sample	O
of	O
dogs	O
(	O
n=361	O
)	O
and	O
cats	O
(	O
n=225	O
)	O
attending	O
29	O
veterinary	O
clinics	I:C2936717
in	O
Auckland	O
during	O
the	O
same	O
period	O
were	O
analysed	O
for	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
by	O
culture	B:C2242979
.	O

Eight	O
methicillin	B:C1265292
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
clinical	O
isolates	O
were	O
submitted	O
for	O
characterisation	O
by	O
the	O
participating	O
laboratories	O
.	O

Eight	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
clinical	O
isolates	B:C1764827
were	O
submitted	O
for	O
characterisation	O
by	O
the	O
participating	O
laboratories	O
.	O

Eight	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
clinical	O
isolates	O
were	O
submitted	O
for	O
characterisation	O
by	O
the	O
participating	O
laboratories	B:C0022877
.	O

The	O
isolates	B:C1764827
originated	O
from	O
five	O
dogs	O
,	O
including	O
two	O
isolates	O
from	O
the	O
same	O
dog	O
,	O
one	O
foal	O
,	O
and	O
one	O
isolate	O
had	O
no	O
identification	O
of	O
the	O
source	O
.	O

The	O
isolates	O
originated	O
from	O
five	O
dogs	B:C0012984
,	O
including	O
two	O
isolates	O
from	O
the	O
same	O
dog	O
,	O
one	O
foal	O
,	O
and	O
one	O
isolate	O
had	O
no	O
identification	O
of	O
the	O
source	O
.	O

The	O
isolates	O
originated	O
from	O
five	O
dogs	O
,	O
including	O
two	O
isolates	B:C1764827
from	O
the	O
same	O
dog	O
,	O
one	O
foal	O
,	O
and	O
one	O
isolate	O
had	O
no	O
identification	O
of	O
the	O
source	O
.	O

The	O
isolates	O
originated	O
from	O
five	O
dogs	O
,	O
including	O
two	O
isolates	O
from	O
the	O
same	O
dog	B:C0012984
,	O
one	O
foal	O
,	O
and	O
one	O
isolate	O
had	O
no	O
identification	O
of	O
the	O
source	O
.	O

The	O
isolates	O
originated	O
from	O
five	O
dogs	O
,	O
including	O
two	O
isolates	O
from	O
the	O
same	O
dog	O
,	O
one	O
foal	O
,	O
and	O
one	O
isolate	B:C1764827
had	O
no	O
identification	O
of	O
the	O
source	O
.	O

The	O
isolates	O
originated	O
from	O
five	O
dogs	O
,	O
including	O
two	O
isolates	O
from	O
the	O
same	O
dog	O
,	O
one	O
foal	O
,	O
and	O
one	O
isolate	O
had	O
no	O
identification	O
of	O
the	O
source	B:C0449416
.	O

The	O
strain	O
-	O
types	O
identified	O
were	O
AK3	B:C1265292
(	I:C1265292
ST	I:C1265292
-	I:C1265292
5	I:C1265292
SCCmecIV	I:C1265292
t045	O
;	O
n=1	O
)	O
,	O
USA500	O
(	I:C1265292
ST8	I:C1265292
SCCmecIV	I:C1265292
t064	O
;	O
n=1	O
)	O
,	O
WSPP	O
(	I:C1265292
ST30	I:C1265292
SCCmecIV	I:C1265292
t019	O
;	O
n=1	O
)	O
,	O
Rhine	O
Hesse	I:C1265292
(	I:C1265292
ST5	I:C1265292
SCCmecII	I:C1265292
t002	O
;	O
n=2	O
)	O
,	O
and	O
EMRSA	O
-	I:C1265292
15	I:C1265292
(	I:C1265292
ST22	I:C1265292
SCCmecIV	I:C1265292
t032	O
;	O
n=3	O
)	O
.	O

The	O
strain	O
-	O
types	O
identified	O
were	O
AK3	O
(	I:C1265292
ST	I:C1265292
-	I:C1265292
5	I:C1265292
SCCmecIV	I:C1265292
t045	O
;	O
n=1	O
)	O
,	O
USA500	B:C1265292
(	I:C1265292
ST8	I:C1265292
SCCmecIV	I:C1265292
t064	O
;	O
n=1	O
)	O
,	O
WSPP	O
(	I:C1265292
ST30	I:C1265292
SCCmecIV	I:C1265292
t019	O
;	O
n=1	O
)	O
,	O
Rhine	O
Hesse	I:C1265292
(	I:C1265292
ST5	I:C1265292
SCCmecII	I:C1265292
t002	O
;	O
n=2	O
)	O
,	O
and	O
EMRSA	O
-	I:C1265292
15	I:C1265292
(	I:C1265292
ST22	I:C1265292
SCCmecIV	I:C1265292
t032	O
;	O
n=3	O
)	O
.	O

The	O
strain	O
-	O
types	O
identified	O
were	O
AK3	O
(	I:C1265292
ST	I:C1265292
-	I:C1265292
5	I:C1265292
SCCmecIV	I:C1265292
t045	O
;	O
n=1	O
)	O
,	O
USA500	O
(	I:C1265292
ST8	I:C1265292
SCCmecIV	I:C1265292
t064	O
;	O
n=1	O
)	O
,	O
WSPP	B:C1265292
(	I:C1265292
ST30	I:C1265292
SCCmecIV	I:C1265292
t019	O
;	O
n=1	O
)	O
,	O
Rhine	O
Hesse	I:C1265292
(	I:C1265292
ST5	I:C1265292
SCCmecII	I:C1265292
t002	O
;	O
n=2	O
)	O
,	O
and	O
EMRSA	O
-	I:C1265292
15	I:C1265292
(	I:C1265292
ST22	I:C1265292
SCCmecIV	I:C1265292
t032	O
;	O
n=3	O
)	O
.	O

The	O
strain	O
-	O
types	O
identified	O
were	O
AK3	O
(	I:C1265292
ST	I:C1265292
-	I:C1265292
5	I:C1265292
SCCmecIV	I:C1265292
t045	O
;	O
n=1	O
)	O
,	O
USA500	O
(	I:C1265292
ST8	I:C1265292
SCCmecIV	I:C1265292
t064	O
;	O
n=1	O
)	O
,	O
WSPP	O
(	I:C1265292
ST30	I:C1265292
SCCmecIV	I:C1265292
t019	O
;	O
n=1	O
)	O
,	O
Rhine	B:C1265292
Hesse	I:C1265292
(	I:C1265292
ST5	I:C1265292
SCCmecII	I:C1265292
t002	O
;	O
n=2	O
)	O
,	O
and	O
EMRSA	O
-	I:C1265292
15	I:C1265292
(	I:C1265292
ST22	I:C1265292
SCCmecIV	I:C1265292
t032	O
;	O
n=3	O
)	O
.	O

The	O
strain	O
-	O
types	O
identified	O
were	O
AK3	O
(	I:C1265292
ST	I:C1265292
-	I:C1265292
5	I:C1265292
SCCmecIV	I:C1265292
t045	O
;	O
n=1	O
)	O
,	O
USA500	O
(	I:C1265292
ST8	I:C1265292
SCCmecIV	I:C1265292
t064	O
;	O
n=1	O
)	O
,	O
WSPP	O
(	I:C1265292
ST30	I:C1265292
SCCmecIV	I:C1265292
t019	O
;	O
n=1	O
)	O
,	O
Rhine	O
Hesse	I:C1265292
(	I:C1265292
ST5	I:C1265292
SCCmecII	I:C1265292
t002	O
;	O
n=2	O
)	O
,	O
and	O
EMRSA	B:C1265292
-	I:C1265292
15	I:C1265292
(	I:C1265292
ST22	I:C1265292
SCCmecIV	I:C1265292
t032	O
;	O
n=3	O
)	O
.	O

No	O
methicillin	B:C1265292
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
were	O
isolated	O
from	O
586	O
cultured	O
swabs	O
.	O

Methicillin	B:C1265292
-	I:C1265292
susceptible	I:C1265292
S.	I:C1265292
aureus	I:C1265292
were	O
detected	O
in	O
9/257	O
(	O
3.5	O
%	O
)	O
swabs	O
and	O
non-aureus	O
staphylococci	I:C0038170
in	O
22/257	O
(	O
8.5	O
%	O
)	O
swabs	O
.	O

Methicillin	O
-	I:C1265292
susceptible	I:C1265292
S.	I:C1265292
aureus	I:C1265292
were	O
detected	B:C0442726
in	O
9/257	O
(	O
3.5	O
%	O
)	O
swabs	O
and	O
non-aureus	O
staphylococci	I:C0038170
in	O
22/257	O
(	O
8.5	O
%	O
)	O
swabs	O
.	O

Methicillin	O
-	I:C1265292
susceptible	I:C1265292
S.	I:C1265292
aureus	I:C1265292
were	O
detected	O
in	O
9/257	O
(	O
3.5	O
%	O
)	O
swabs	O
and	O
non-aureus	B:C0038170
staphylococci	I:C0038170
in	O
22/257	O
(	O
8.5	O
%	O
)	O
swabs	O
.	O

The	O
estimated	O
true	O
methicillin	B:C1265292
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
subclinical	O
colonisation	O
prevalence	O
was	O
0	O
%	O
,	O
with	O
an	O
upper	O
95	O
%	O
CI	O
boundary	O
of	O
1.9	O
%	O
for	O
cats	O
and	O
1.4	O
%	O
for	O
dogs	O
.	O

The	O
estimated	O
true	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
subclinical	O
colonisation	B:C2242741
prevalence	O
was	O
0	O
%	O
,	O
with	O
an	O
upper	O
95	O
%	O
CI	O
boundary	O
of	O
1.9	O
%	O
for	O
cats	O
and	O
1.4	O
%	O
for	O
dogs	O
.	O

The	O
estimated	O
true	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
subclinical	O
colonisation	O
prevalence	O
was	O
0	O
%	O
,	O
with	O
an	O
upper	O
95	O
%	O
CI	O
boundary	O
of	O
1.9	O
%	O
for	O
cats	B:C0007450
and	O
1.4	O
%	O
for	O
dogs	O
.	O

The	O
estimated	O
true	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
subclinical	O
colonisation	O
prevalence	O
was	O
0	O
%	O
,	O
with	O
an	O
upper	O
95	O
%	O
CI	O
boundary	O
of	O
1.9	O
%	O
for	O
cats	O
and	O
1.4	O
%	O
for	O
dogs	B:C0012984
.	O

The	O
modest	O
number	O
of	O
methicillin	B:C1265292
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
isolates	O
submitted	O
for	O
this	O
study	O
by	O
the	O
participating	O
laboratories	O
suggests	O
clinical	O
MRSA	O
infection	I:C0343401
in	O
animals	O
in	O
New	O
Zealand	I:C0027978
continues	O
to	O
be	O
sporadic	O
.	O

The	O
modest	O
number	O
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
isolates	B:C1764827
submitted	O
for	O
this	O
study	O
by	O
the	O
participating	O
laboratories	O
suggests	O
clinical	O
MRSA	O
infection	I:C0343401
in	O
animals	O
in	O
New	O
Zealand	I:C0027978
continues	O
to	O
be	O
sporadic	O
.	O

The	O
modest	O
number	O
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
isolates	O
submitted	O
for	O
this	O
study	B:C0085973
by	O
the	O
participating	O
laboratories	O
suggests	O
clinical	O
MRSA	O
infection	I:C0343401
in	O
animals	O
in	O
New	O
Zealand	I:C0027978
continues	O
to	O
be	O
sporadic	O
.	O

The	O
modest	O
number	O
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
isolates	O
submitted	O
for	O
this	O
study	O
by	O
the	O
participating	O
laboratories	B:C0022877
suggests	O
clinical	O
MRSA	O
infection	I:C0343401
in	O
animals	O
in	O
New	O
Zealand	I:C0027978
continues	O
to	O
be	O
sporadic	O
.	O

The	O
modest	O
number	O
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
isolates	O
submitted	O
for	O
this	O
study	O
by	O
the	O
participating	O
laboratories	O
suggests	O
clinical	O
MRSA	B:C0343401
infection	I:C0343401
in	O
animals	O
in	O
New	O
Zealand	I:C0027978
continues	O
to	O
be	O
sporadic	O
.	O

The	O
modest	O
number	O
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
isolates	O
submitted	O
for	O
this	O
study	O
by	O
the	O
participating	O
laboratories	O
suggests	O
clinical	O
MRSA	O
infection	I:C0343401
in	O
animals	B:C0003062
in	O
New	O
Zealand	I:C0027978
continues	O
to	O
be	O
sporadic	O
.	O

The	O
modest	O
number	O
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
isolates	O
submitted	O
for	O
this	O
study	O
by	O
the	O
participating	O
laboratories	O
suggests	O
clinical	O
MRSA	O
infection	I:C0343401
in	O
animals	O
in	O
New	B:C0027978
Zealand	I:C0027978
continues	O
to	O
be	O
sporadic	O
.	O

The	O
wide	O
variety	O
of	O
strain	O
-	O
types	O
found	O
mirrored	O
the	O
evolving	O
strain	O
-	O
type	O
diversity	O
observed	O
in	O
humans	B:C0086418
.	O

We	O
can	O
not	O
rule	O
out	O
bias	O
due	O
to	O
the	O
non-random	B:C0150105
sampling	I:C0150105
of	O
dogs	O
and	O
cats	O
,	O
but	O
the	O
apparent	O
colonisation	O
prevalence	O
of	O
0	O
%	O
was	O
consistent	O
with	O
the	O
low	O
prevalence	O
of	O
subclinical	O
colonisation	O
in	O
humans	O
in	O
New	O
Zealand	I:C0027978
.	O

We	O
can	O
not	O
rule	O
out	O
bias	O
due	O
to	O
the	O
non-random	O
sampling	I:C0150105
of	O
dogs	B:C0012984
and	O
cats	O
,	O
but	O
the	O
apparent	O
colonisation	O
prevalence	O
of	O
0	O
%	O
was	O
consistent	O
with	O
the	O
low	O
prevalence	O
of	O
subclinical	O
colonisation	O
in	O
humans	O
in	O
New	O
Zealand	I:C0027978
.	O

We	O
can	O
not	O
rule	O
out	O
bias	O
due	O
to	O
the	O
non-random	O
sampling	I:C0150105
of	O
dogs	O
and	O
cats	B:C0007450
,	O
but	O
the	O
apparent	O
colonisation	O
prevalence	O
of	O
0	O
%	O
was	O
consistent	O
with	O
the	O
low	O
prevalence	O
of	O
subclinical	O
colonisation	O
in	O
humans	O
in	O
New	O
Zealand	I:C0027978
.	O

We	O
can	O
not	O
rule	O
out	O
bias	O
due	O
to	O
the	O
non-random	O
sampling	I:C0150105
of	O
dogs	O
and	O
cats	O
,	O
but	O
the	O
apparent	O
colonisation	B:C4289767
prevalence	O
of	O
0	O
%	O
was	O
consistent	O
with	O
the	O
low	O
prevalence	O
of	O
subclinical	O
colonisation	O
in	O
humans	O
in	O
New	O
Zealand	I:C0027978
.	O

We	O
can	O
not	O
rule	O
out	O
bias	O
due	O
to	O
the	O
non-random	O
sampling	I:C0150105
of	O
dogs	O
and	O
cats	O
,	O
but	O
the	O
apparent	O
colonisation	O
prevalence	O
of	O
0	O
%	O
was	O
consistent	O
with	O
the	O
low	O
prevalence	O
of	O
subclinical	O
colonisation	B:C2242741
in	O
humans	O
in	O
New	O
Zealand	I:C0027978
.	O

We	O
can	O
not	O
rule	O
out	O
bias	O
due	O
to	O
the	O
non-random	O
sampling	I:C0150105
of	O
dogs	O
and	O
cats	O
,	O
but	O
the	O
apparent	O
colonisation	O
prevalence	O
of	O
0	O
%	O
was	O
consistent	O
with	O
the	O
low	O
prevalence	O
of	O
subclinical	O
colonisation	O
in	O
humans	B:C0086418
in	O
New	O
Zealand	I:C0027978
.	O

We	O
can	O
not	O
rule	O
out	O
bias	O
due	O
to	O
the	O
non-random	O
sampling	I:C0150105
of	O
dogs	O
and	O
cats	O
,	O
but	O
the	O
apparent	O
colonisation	O
prevalence	O
of	O
0	O
%	O
was	O
consistent	O
with	O
the	O
low	O
prevalence	O
of	O
subclinical	O
colonisation	O
in	O
humans	O
in	O
New	B:C0027978
Zealand	I:C0027978
.	O

These	O
similarities	O
indicate	O
the	O
epidemiology	B:C0014507
of	O
animal	O
and	O
human	O
MRSA	O
infections	I:C0343401
are	O
linked	O
.	O

These	O
similarities	O
indicate	O
the	O
epidemiology	O
of	O
animal	B:C0003062
and	O
human	O
MRSA	O
infections	I:C0343401
are	O
linked	O
.	O

These	O
similarities	O
indicate	O
the	O
epidemiology	O
of	O
animal	O
and	O
human	B:C0086418
MRSA	O
infections	I:C0343401
are	O
linked	O
.	O

These	O
similarities	O
indicate	O
the	O
epidemiology	O
of	O
animal	O
and	O
human	O
MRSA	B:C0343401
infections	I:C0343401
are	O
linked	O
.	O

In	O
the	O
last	O
decade	O
,	O
the	O
prevalence	O
of	O
human	B:C0086418
MRSA	O
infections	I:C0343401
in	O
New	O
Zealand	I:C0027978
has	O
steadily	O
increased	O
.	O

In	O
the	O
last	O
decade	O
,	O
the	O
prevalence	O
of	O
human	O
MRSA	B:C0343401
infections	I:C0343401
in	O
New	O
Zealand	I:C0027978
has	O
steadily	O
increased	O
.	O

In	O
the	O
last	O
decade	O
,	O
the	O
prevalence	O
of	O
human	O
MRSA	O
infections	I:C0343401
in	O
New	B:C0027978
Zealand	I:C0027978
has	O
steadily	O
increased	O
.	O

This	O
is	O
the	O
second	O
published	O
study	B:C0085973
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
in	O
animals	O
in	O
New	O
Zealand	I:C0027978
.	O

This	O
is	O
the	O
second	O
published	O
study	O
of	O
methicillin	B:C1265292
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
in	O
animals	O
in	O
New	O
Zealand	I:C0027978
.	O

This	O
is	O
the	O
second	O
published	O
study	O
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
in	O
animals	B:C0003062
in	O
New	O
Zealand	I:C0027978
.	O

This	O
is	O
the	O
second	O
published	O
study	O
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
Staphylococcus	I:C1265292
aureus	I:C1265292
in	O
animals	O
in	O
New	B:C0027978
Zealand	I:C0027978
.	O

The	O
results	O
indicate	O
clinical	O
MRSA	B:C0343401
infection	I:C0343401
in	O
animals	O
remains	O
sporadic	O
,	O
but	O
the	O
diversification	O
of	O
the	O
strain	O
-	O
types	O
may	O
pose	O
new	O
therapeutic	O
challenges	O
to	O
veterinarians	O
,	O
due	O
to	O
their	O
diverse	O
resistome	O
.	O

The	O
results	O
indicate	O
clinical	O
MRSA	O
infection	I:C0343401
in	O
animals	B:C0003062
remains	O
sporadic	O
,	O
but	O
the	O
diversification	O
of	O
the	O
strain	O
-	O
types	O
may	O
pose	O
new	O
therapeutic	O
challenges	O
to	O
veterinarians	O
,	O
due	O
to	O
their	O
diverse	O
resistome	O
.	O

The	O
results	O
indicate	O
clinical	O
MRSA	O
infection	I:C0343401
in	O
animals	O
remains	O
sporadic	O
,	O
but	O
the	O
diversification	O
of	O
the	O
strain	O
-	O
types	O
may	O
pose	O
new	O
therapeutic	O
challenges	O
to	O
veterinarians	B:C0242856
,	O
due	O
to	O
their	O
diverse	O
resistome	O
.	O

